Research Topics
Species | V W RuschSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Initial analysis of the international association for the study of lung cancer mesothelioma databaseValerie W Rusch
Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Thorac Oncol 7:1631-9. 2012..To plan revisions of this system, the International Association for the Study of Lung Cancer Staging Committee developed an international database. Initial analyses focus on patients managed surgically...
The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancerValerie W Rusch
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Thorac Oncol 2:603-12. 2007..We sought to determine whether the current N descriptors should be maintained or revised for the next edition of the international lung cancer staging system...
Surgery for bronchioloalveolar carcinoma and "very early" adenocarcinoma: an evolving standard of care?Valerie W Rusch
Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Thorac Oncol 1:S27-31. 2006..To improve our management of very early AC, much more information is needed about the molecular abnormalities of AC and their relationship to clinical outcomes...
The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancerValerie W Rusch
Thoracic Surgery Service, Memorial Sloan Kettering Cancer Center, New York City, New York 10065, USA
J Thorac Oncol 4:568-77. 2009..A method of grouping lymph node stations together into "zones" is also proposed for the purposes of future survival analyses...
Management of Pancoast tumoursValerie W Rusch
Thoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Lancet Oncol 7:997-1005. 2006..This review includes discussion of anatomical considerations, initial assessment, multimodality treatment, and surgical approaches for these cancers...
Nael Martini: a leader in thoracic surgical oncologyValerie W Rusch
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Ann Thorac Surg 89:1006-9. 2010..Nael Martini was one of the leading academic general thoracic surgeons of the late 20th century. His most notable contributions related to the surgical and multimodality treatment of lung cancer...
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesotheliomaV W Rusch
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Thorac Cardiovasc Surg 122:788-95. 2001..We performed a phase II trial of high-dose hemithoracic radiation after complete resection to determine feasibility and to estimate rates of local recurrence and survival...
Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trialValerie W Rusch
Thoracic Surgery Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
J Clin Oncol 29:4313-9. 2011..We investigated the prevalence of OMs in resectable NSCLC and their relationship with survival...
Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcusV W Rusch
Thoracic Surgery, Orthopedic Surgery, and Neurosurgery Services, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Thorac Cardiovasc Surg 119:1147-53. 2000..To establish a historical benchmark against which new therapies can be assessed, we reviewed our 24-year experience with patients undergoing thoracotomy for lung cancers of the superior sulcus...
Important prognostic factors in patients with malignant pleural mesothelioma, managed surgicallyV W Rusch
Department of Surgery, and Biostatistics Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 68:1799-804. 1999..The factors influencing outcome after resection of malignant pleural mesothelioma (MPM) are controversial. This analysis of a prospective surgical database identifies important prognostic factors...
Indications for pneumonectomy. Extrapleural pneumonectomyV W Rusch
Thoracic Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Chest Surg Clin N Am 9:327-38, x. 1999..The potential role of extrapleural pneumonectomy in MPM is best considered in this context...
The epidermal growth factor receptor and its ligands as therapeutic targets in human tumorsV Rusch
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cytokine Growth Factor Rev 7:133-41. 1996....
Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomyJ Martin
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 72:1149-54. 2001..However, right pneumonectomy is associated with a significantly increased risk and should be performed only in selected patients...
Feasibility of multimodality therapy including extended resections in stage IVA thymomaJames Huang
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Thorac Cardiovasc Surg 134:1477-83; discussion 1483-4. 2007..We reviewed our experience with multimodality treatment for Masaoka stage IVA thymomas for feasibility and outcomes...
Incidence and risk factors for lung injury after lung cancer resectionNaveed Alam
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 84:1085-91; discussion 1091. 2007..Our objective was to identify the incidence and risk factors for the development of postoperative lung injury...
The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung CancerWilliam D Travis
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Thorac Oncol 3:1213-23. 2008....
Extent of chest wall invasion and survival in patients with lung cancerR J Downey
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 68:188-93. 1999....
Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar componentsInderpal S Sarkaria
Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 85:216-23. 2008..This study assesses EGFR signaling in these tumors...
Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancerInderpal S Sarkaria
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Ann Surg 249:764-7. 2009..We wanted to determine if endoscopic biopsy can accurately establish evidence of local pathologic complete response (pCR) in patients undergoing CRT...
Use of video-assisted thoracic surgery for lobectomy in the elderly results in fewer complicationsStephen M Cattaneo
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 85:231-5; discussion 235-6. 2008....
Successful treatment of esophageal cancer with airway invasion with induction chemotherapy and concurrent chemoradiotherapyGeoffrey Y Ku
Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Thorac Oncol 4:432-4. 2009..Such a staged approach may reduce the morbidity of upfront radiation. The use of an interim positron emission tomography scan may also identify early treatment failure...
Resection of superior sulcus tumors (posterior approach)Michael S Kent
Thoracic Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, USA
Thorac Surg Clin 14:217-28. 2004..Involvement of the vertebral body or brachial plexus, areas once considered unresectable, is amenable to advanced techniques of spinal reconstruction and may lead to long-term survival in selected patients...
Long-term results of combined-modality therapy in resectable non-small-cell lung cancerJocelyne Martin
Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 20:1989-95. 2002..Survival is significantly influenced by patient age, complete resection, pathologic stage, and pneumonectomy. These results can help guide standard clinical practice and emphasize the need for novel induction regimens...
Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcomeAndrew P Barbour
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg Oncol 14:306-16. 2007..The aim of this study was to determine whether adequate staging revealed different prognostic factors or improved survival compared with patients with <15 nodes examined after R0 resection for GEJ cancer...
Tension pneumocephalus resulting from iatrogenic subarachnoid-pleural fistulae: report of three casesM H Bilsky
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 71:455-7. 2001..Symptomatic pneumocephalus may result from a cerebrospinal fluid leak communicating with extradural air. However, it is a rare event after thoracic surgical procedures, and its management and physiology are not widely recognized...
Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinomaJenifer L Marks
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Thorac Oncol 3:111-6. 2008..Whether EGFR and KRAS mutations also have an impact on survival in patients who undergo lung resection for curative intent in the absence of targeted therapy has not been established...
The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinomaNabil P Rizk
Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 198:42-50. 2004..CONCLUSIONS: Technical complications have a large negative impact on survival after esophagogastrectomy for cancer. Strategies to optimize surgical technique and minimize complications should improve outcomes in this cancer operation...
Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesotheliomaVishal Gupta
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 63:1045-52. 2005..Our results imply that residual disease cannot be eradicated with external RT with or without brachytherapy and that a more extensive surgery followed by external RT might be required to improve local control and overall survival...
A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumorsGabriel Sica
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Am J Surg Pathol 34:1155-62. 2010..65 (95% confidence interval 0.57-0.73). Therefore, this scoring system provides valuable information in discriminating patients with different risk of disease-recurrence in a highly homogeneous population of patients with stage I cancer...
Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinomaMichael I Ebright
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 74:1640-6; discussion 1646-7. 2002..The favorable survival of stage III/IV BAC indicates that the current staging system does not fully describe this disease in patients undergoing resection because of its distinct tumor behavior...
Surgical techniques for nonseminomatous germ cell tumors metastatic to the lungDaniel J Boffa
Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Chest Surg Clin N Am 12:739-48. 2002....
Predictors of outcomes after surgical treatment of synchronous primary lung cancersDavid J Finley
Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center, New York City, New York 10021, USA
J Thorac Oncol 5:197-205. 2010..Determining this distinction with certainty, however, is challenging. We reviewed our experience with surgical resection of presumed SPLC to analyze outcomes and identify factors associated with prolonged survival...
Optimum lymphadenectomy for esophageal cancerNabil P Rizk
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg 251:46-50. 2010..Using Worldwide Esophageal Cancer Collaboration data, we sought to (1) characterize the relationship between survival and extent of lymphadenectomy, and (2) from this, define optimum lymphadenectomy...
Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experienceG Y Ku
Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Ann Oncol 19:533-7. 2008..Esophageal small-cell carcinoma (SCC) is rare, highly malignant and the optimal treatment approach has not been defined...
Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgeryD Amar
Departments of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Thorac Cardiovasc Surg 120:790-8. 2000..We sought to determine whether early prophylaxis with an L -type calcium channel blocker reduces the incidence and morbidity associated with atrial fibrillation/flutter and supraventricular tachyarrhythmia after major thoracic operations...
Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)V W Rusch
Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
J Thorac Cardiovasc Surg 121:472-83. 2001....
Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patientsT L Weigel
Thoracic Surgery Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 71:967-70. 2001..Fluorescence bronchoscopy appears to be a sensitive tool for surveillance of the tracheobronchial tree for early neoplasias...
Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)Valerie W Rusch
Thoracic Surgery Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Clin Oncol 25:313-8. 2007..On the basis of improved outcomes in other subsets of stage III NSCLC, this trial tested the feasibility of induction chemoradiotherapy for SS NSCLC...
Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junctionAndrew P Barbour
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 205:593-601. 2007..The purpose of this study was to compare preoperative EUS staging with postoperative pathologic staging and to assess the ability of EUS to predict survival after resection for GEJ adenocarcinoma...
Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomasDuyKhanh Pham
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Clin Oncol 24:1700-4. 2006..Investigators have reported an association between EGFR mutations and the amount and duration of cigarette smoking, with the highest incidence of mutations seen in never smokers...
Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysisStephen B Solomon
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Howard 118, New York, NY 10021, USA
AJR Am J Roentgenol 194:266-9. 2010....
Therapeutic sentinel lymph node imagingStefan S Kachala
Division of Thoracic Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Semin Thorac Cardiovasc Surg 21:327-38. 2009..In this review, we summarize the novel preclinical agents for identification and treatment of tumor bearing LNs and discuss their potential for clinical translation...
SCCRO expression correlates with invasive progression in bronchioloalveolar carcinomaInderpal S Sarkaria
Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 78:1734-41. 2004..We hypothesized that SCCRO expression would correlate with invasive tumor phenotypes and worse survival in BAC...
Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelinesNicolas Girard
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Chest 137:46-52. 2010..Here, we report on seven patients in whom epidermal growth factor receptor (EGFR) and Kirsten-rat sarcoma 2 viral oncogene homolog (KRAS) tumor mutation status was used to determine clonal relationships among multiple lung lesions...
Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scansFan Liu
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, Columbia University, New York, New York
J Thorac Oncol 5:879-84. 2010....
Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapyVishal Gupta
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY 10065, USA
J Thorac Oncol 4:746-50. 2009....
Insulin-like growth factor-1 receptor expression in thymic malignanciesNicolas Girard
Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY 10065, USA
J Thorac Oncol 5:1439-46. 2010..As higher levels of IGF-1R protein expression may be associated with relative sensitivity to anti-IGF-1R antibody treatment, we investigated IGF-1R expression in thymic malignancies...
Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcomeAndrew P Barbour
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 246:1-8. 2007..To determine whether the length of esophageal resection or the operative approach influences outcome for patients with adenocarcinoma of the gastroesophageal junction (GEJ)...
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaWilliam D Travis
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Thorac Oncol 6:244-85. 2011....
Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesotheliomaPrasad S Adusumilli
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 14:258-69. 2007..Such stress response is beneficial for oncolytic viral therapy. We hypothesized that a combination of RT and NV1066, an oncolytic herpes virus, might exert an additive or synergistic effect in the treatment of MPM...
Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancerRaja M Flores
Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Thorac Cardiovasc Surg 138:11-8. 2009..However, a well-balanced comparison of the two procedures is lacking in the literature...
Comparison of patterns of relapse in thymic carcinoma and thymomaJames Huang
Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Thorac Cardiovasc Surg 138:26-31. 2009..We reviewed our recent experience with the surgical management of thymic tumors and compared the outcomes and patterns of relapse between patients with thymic carcinoma and those with thymoma...
Predictive value of initial PET-SUVmax in patients with locally advanced esophageal and gastroesophageal junction adenocarcinomaNabil P Rizk
Memorial Sloan Kettering Cancer Center, New York City, New York 10021, USA
J Thorac Oncol 4:875-9. 2009..In this study, we analyze the impact of the pretreatment PET SUVmax in patients with locally advanced esophageal adenocarcinoma who undergo preoperative chemoradiotherapy...
Prognostic factors after combined modality treatment of squamous cell carcinoma of the esophagusNabil P Rizk
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Room C 883, New York, NY 10021, USA
J Thorac Oncol 2:1117-23. 2007..In this study, we evaluated prognostic factors among patients with squamous cell carcinoma (SCC) of the esophagus who have undergone a similar treatment regimen...
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesotheliomaLee M Krug
Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Clin Oncol 27:3007-13. 2009....
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patientsRaja M Flores
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Thorac Cardiovasc Surg 135:620-6, 626.e1-3. 2008..We performed a multi-institutional study to increase statistical power to detect significant differences in outcome between extrapleural pneumonectomy and pleurectomy/decortication...
Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinibMaureen F Zakowski
Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Arch Pathol Lab Med 133:470-7. 2009..A subset of lung adenocarcinomas appears preferentially sensitive to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). EGFR-activating mutations and never smoking are associated with response to TKIs...
DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumorsIrene Orlow
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 26:3560-6. 2008..Therefore, we evaluated constitutive and induced DNA damage, and repair capacity, in patients with multiple NSCLCs (cases) and compared the results to those obtained in patients with a single NSCLC (controls)...
The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging systemRaja M Flores
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Thorac Cardiovasc Surg 136:605-10. 2008..The American Joint Committee on Cancer staging system groups N1 and N2 disease together as stage III. The goal of this study was to define the prognostic value of specific nodal stations...
Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysisNoriko Motoi
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Am J Surg Pathol 32:810-27. 2008..Such an approach should be considered in future studies for validation in other datasets...
Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trialRaja M Flores
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Thorac Oncol 1:289-95. 2006..We designed this clinical trial to test the feasibility of induction chemotherapy followed by EPP and RT in locally advanced MPM with the ultimate aim of improving survival...
A pilot trial of high-dose-rate intraoperative radiation therapy for malignant pleural mesotheliomaKenneth E Rosenzweig
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Brachytherapy 4:30-3. 2005..To report results of a phase II trial of high-dose-rate intra-operative radiation therapy (HDR-IORT) for malignant pleural mesothelioma (MPM)...
Robotic assistance for video-assisted thoracic surgical lobectomy: technique and initial resultsBernard J Park
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Thorac Cardiovasc Surg 131:54-9. 2006..There is little experience with telerobotic assistance for video-assisted thoracic surgical lobectomy. We developed a technique for robotic assistance during video-assisted thoracic surgical lobectomy and report our initial results...
Surgical management of thoracic malignancies invading the heart or great vesselsBernard J Park
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 78:1024-30. 2004..We reviewed our experience of 10 patients treated surgically, either primarily or as a component of multimodality therapy, to assess feasibility and results...
Positron emission tomography predicts survival in malignant pleural mesotheliomaRaja M Flores
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Thorac Cardiovasc Surg 132:763-8. 2006..Because mediastinal nodal metastasis is known to be associated with poor prognosis, we hypothesized that standard uptake value on fluorodeoxyglucose positron emission tomography might independently predict survival...
Extrapleural pneumonectomy in childrenRaja M Flores
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Pediatr Surg 41:1738-42. 2006..EPP in the pediatric population has not been reported in the literature. We report our experience of using EPP in children to treat a variety of malignancies that involve the pleural surface...
Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-ASimon G Talbot
Laboratory of Epithelial Cancer, Biology, and Head and Neck Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg Oncol 11:530-4. 2004..The present study aims to confirm and validate this link between SCCRO and VEGF-A expression in an ex vivo human tumor cohort...
An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancerTim Akhurst
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 73:259-64; discussion 264-6. 2002..Aside from one 9-patient study, there are no data comparing FDG-PET imaging with surgical staging of NSCLC after induction therapy...
Management of major hemorrhage during mediastinoscopyBernard J Park
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Room C 867, New York, NY 10021, USA
J Thorac Cardiovasc Surg 126:726-31. 2003..The management of major hemorrhage complicating mediastinoscopy is not well described. We reviewed our experience to determine the frequency, optimal management strategy, and outcome of these injuries...
A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasisRobert J Downey
Thoracic Services, Memorial Sloan Kettering Cancer Center, Division of Thoracic Surgery, 1275 York Avenue, New York, NY 10021, USA
Lung Cancer 38:193-7. 2002..The feasibility and potential benefit of combining surgery and chemotherapy in this setting are unclear. Therefore, we performed a prospective trial to test this therapeutic approach...
Video-assisted thoracic surgery does not reduce the incidence of postoperative atrial fibrillation after pulmonary lobectomyBernard J Park
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Thorac Cardiovasc Surg 133:775-9. 2007..The objective was to define the incidence of atrial fibrillation after video-assisted thoracic surgery lobectomy and determine whether video-assisted thoracic surgery reduces atrial fibrillation rate compared with thoracotomy...
Surgical treatment of superior sulcus tumors with spinal and brachial plexus involvementMark H Bilsky
Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Neurosurg 97:301-9. 2002..Advances in spinal surgery, the application of magnetic resonance (MR) imaging, and improvements in neoadjuvant therapy require a reassessment of the potential for complete resection...
American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinomaNabil P Rizk
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 25:507-12. 2007..However, none of these methods has been formally evaluated. The purpose of this study was to establish prognostic pathologic variables after CRT...
Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesotheliomaSantosh Yajnik
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 56:1319-26. 2003..Our institution recently published results showing that extrapleural pneumonectomy (EPP) followed by hemithoracic radiation yielded excellent local control. This paper reports our technique for high-dose hemithoracic radiation after EPP...
Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesotheliomaRaja M Flores
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Thorac Cardiovasc Surg 126:11-6. 2003..Small studies suggest that fluorodeoxyglucose-positron emission tomography may improve staging. We analyzed our experience to determine more definitively the potential utility of fluorodeoxyglucose-positron emission tomography...
Virally-directed fluorescent imaging (VFI) can facilitate endoscopic stagingP S Adusumilli
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Surg Endosc 20:628-35. 2006..CONCLUSION: Virally-directed fluorescent imaging (VFI) is a real-time novel molecular imaging technology that has the potential to enhance the intraoperative detection of endoluminal or endocavitary tumor nodules...
Are cancers of the esophagus, gastroesophageal junction, and cardia one disease, two, or several?Valerie W Rusch
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Semin Oncol 31:444-9. 2004..Much more investigation is required to confirm or refute these apparent differences, which can affect clinical treatment...
Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinumsN Z Khokhar
Program in Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Clin Cancer Res 7:3199-205. 2001..These results strongly suggest that PDX has significant potential in the treatment of human pleural mesothelioma, particularly when coadministered with probenecid or combined with platinum compounds...
Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancerB M Stiles
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Cancer Gene Ther 13:53-64. 2006....
Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesotheliomaPrasad S Adusumilli
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer Biol Ther 5:48-53. 2006..5-deficient oncolytic virus, NV1066. This provides a cellular basis for combination therapy with cisplatin and NV1066 to treat MPM and achieve synergistic efficacy, while minimizing dosage and toxicity...
Adjuvant therapy in non-small cell lung cancerValerie W Rusch
Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Ann Thorac Surg 84:1793-4. 2007
A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesotheliomaValerie W Rusch
Eur J Cardiothorac Surg 31:534-5. 2007
Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?Valerie W Rusch
J Clin Oncol 21:2629-30. 2003
Should the esophageal cancer staging system be revised?Valerie W Rusch
J Thorac Cardiovasc Surg 125:992-3. 2003
The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trialBryan F Meyers
Department of Surgery, Washington University School of Medicine, St Louis, MO
J Thorac Cardiovasc Surg 133:738-45. 2007....
Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancerDavid H Johnson
J Natl Cancer Inst 99:415-8. 2007
High-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lungValerie W Rusch
J Thorac Cardiovasc Surg 124:221-2. 2002
Surgical techniques for pulmonary metastasectomyValerie W Rusch
Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Semin Thorac Cardiovasc Surg 14:4-9. 2002..Stapled and precision electrocautery wedge resections remain the most common techniques for parenchymal resection...
Mortality increases for octogenarians undergoing esophagogastrectomy for esophageal cancerAlexander H Moskovitz
Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 82:2031-6; discussion 2036. 2006..9; p < 0.01). CONCLUSIONS: Patients older than 80 years have increased mortality risk after esophagectomy, independent of comorbidity. Octogenarian status should be a consideration in the management of these patients...
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancerCarolyn E Reed
Hollings Cancer Center, Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston 29425, USA
J Thorac Cardiovasc Surg 126:1943-51. 2003....
Patterns of surgical care of lung cancer patientsAlex G Little
Department of Surgery, Wright State University School of Medicine, Dayton, Ohio, USA
Ann Thorac Surg 80:2051-6; discussion 2056. 2005..This survey was performed to determine the patterns of surgical care provided patients with non-small cell lung carcinoma (NSCLC)...
Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancerPrasad S Adusumilli
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 80:409-16; discussion 416-7. 2005....
Prediction rule for atrial fibrillation after major noncardiac thoracic surgeryRod S Passman
Northwestern University Feinberg School of Medicine and the Feinberg Cardiovascular Institute, Chicago, Illinois 60611, USA
Ann Thorac Surg 79:1698-703. 2005..We sought to derive and validate a clinical prediction rule to risk-stratify patients for postoperative AF...
Results of chest wall resection and reconstruction with and without rigid prosthesisMichael J Weyant
Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Thorac Surg 81:279-85. 2006..Pneumonectomy plus chest wall resection should be performed only in highly selected patients...
Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trialMark S Allen
Ann Thorac Surg 81:1013-9; discussion 1019-20. 2006..Little prospective, multiinstitutional data exist regarding the morbidity and mortality after major pulmonary resections for lung cancer or whether a mediastinal lymph node dissection increases morbidity and mortality...
Multimodality therapy for locally advanced thymomas: state of the art or investigational therapy?James Huang
Ann Thorac Surg 85:365-7. 2008
Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancerKatherine E Posther
Department of Surgery, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, North Carolina, USA
J Nucl Med 47:1607-11. 2006....
Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer CentersGeoffrey A Porter
Dalhousie University, Halifax, Nova Scotia, Canada
J Thorac Cardiovasc Surg 127:1366-72. 2004..We sought to determine the cost-effectiveness of different treatment strategies for patients with pulmonary metastases from soft tissue sarcoma...
Mediastinoscopy: an endangered species?Valerie W Rusch
J Clin Oncol 23:8283-5. 2005
